NOV 22, 2015 09:15 AM PST

Kill Cancer with an Intelligent, Injectable Gel?

WRITTEN BY: Xuan Pham
A new way of treating cancer may come in the form of an injectable gel. The “biogel” was developed in lab of Réjean Lapointe at the University of Montreal Hospital Research Centre, to provide a better way to deliver anti-cancer immune cells to patients.
 
Researchers examine the injectable cancer-killing gel

“The strength of this biogel is that it is compatible with anti-cancer immune cells. It is used to encapsulate these cells and eventually administer them using a syringe or catheter into the tumour or directly beside it. Instead of injecting these cells or anti-cancer drugs throughout the entire body via the bloodstream, we can treat the cancer locally. We hope that this targeted approach will improve current immunotherapies.” Réjean Lapointe, senior author of the study.
 
Current immunotherapy techniques that use the patient’s own T cells to fight off cancer has been well established. But because the body’s natural T cells are insufficient in number and strength to fight off cancer fully, scientists devised a method give the T cells more firepower. Known as adoptive cell therapy (ACT), scientists collect the patient’s own T cells, modify them to enhance tumor recognition, increase their numbers to billions, and then inject them back into the patient to finish the job.
 
While this technique has shown to be effective in small trials involving leukemia and lymphoma patients, there are several limitations: extraordinarily high cell count requirement, and toxicity due to high doses of interleukin-2, a hormone added to maximize effectiveness.
 
The biogel breaks through these limitations as it requires millions of T cells instead of billions, and in the process, significantly reduces the toxicity by the interleukin-2 hormone. Developed by Sophie Lerouge, the biogel is made from biodegradable material taken from the shells of crustaceans. The biogel is liquid at room temperature and becomes a cohesive gel at 37 degrees Celsius, the human body temperature. Additionally, the biogel is non-toxic to the body and “provided excellent survival and growth of the encapsulated cells,” said Lerouge. Once inside the body, the gel serves as a “cellular reservoir” deploying and renewing the cancer-killing T cells.
 
"The T lymphocytes in the gel are functional and can grow for two to three weeks, be released from the gel, and kill the cancerous cells," explained Réjean Lapointe, senior author.
 
Early in vitro experiments testing the gel on melanoma and kidney cancer models have so far been reported as successful. The researchers plan to test the biogel in animal models, and if effective, will move towards human trials. If the biogel performs well, the tool will likely be adapted to treat many types of cancer in the next few years.
 
 
Sources: BioMaterials, Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 28, 2018
Clinical & Molecular DX
MAY 28, 2018
Bacterial Toxin Linked to Inflammatory Bowel Disease
Scientists have found evidence that it's not a bacterium, but one of its toxins, that is connected to, and possibly causing intestinal dysfunction....
JUN 12, 2018
Immunology
JUN 12, 2018
Auto-antibody Detection for Rheumatoid Arthritis Patients
No case of rheumatoid arthritis (RA), an autoimmune disease, is the same. Now, researchers want RA diagnostic approaches to match its pathological diversit...
JUN 16, 2018
Videos
JUN 16, 2018
What is Preimplantation Genetic Diagnosis?
All parents want a healthy baby, and for some people that carry genetic mutations, the decision to have children presents a challenge....
JUL 13, 2018
Genetics & Genomics
JUL 13, 2018
Detecting Leukemia Before it Starts Growing
Researchers have found ways to identify people who may develop an aggressive type of blood cancer while they are still healthy....
JUL 19, 2018
Microbiology
JUL 19, 2018
Mom's Microbiome has a Big Impact on Kid's Autism Risk
For many years, scientists have been trying to learn more about the causes of autism....
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
Biomarker Predicts Kidney Cancer
A research study led by Beth Israel Deaconess Medical Center has discovered a tumor biomarker that could be used to determine the onset of renal cell carci...
Loading Comments...